Evidence map›Paper›PMID 39519680›Full record

ArticleMolecules (Basel, Switzerland)2024

A Simple HPLC-DAD Method for the Therapeutic Monitoring of Clozapine and Related Metabolites in Human Plasma and Urine Samples.

Mircea-Alexandru Comănescu, Dana-Maria Preda, Dalia-Simona Miron, Flavian-Ștefan Rădulescu, Victor Voicu, Andrei-Valentin Medvedovici

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mircea-Alexandru ComănescuDepartment of Analytical & Physical Chemistry, Faculty of Chemistry, University of Bucharest, Panduri Ave. # 90-92, 050663 Bucharest, Romania.ORCID 0000-0002-3075-436X
Dana-Maria PredaDepartment of Analytical & Physical Chemistry, Faculty of Chemistry, University of Bucharest, Panduri Ave. # 90-92, 050663 Bucharest, Romania.
Dalia-Simona MironCenter for Drug Sciences, Faculty of Pharmacy, University of Medicine and Pharmacy Carol Davila Bucharest, #6 Traian Vuia Street, 025956 Bucharest, Romania.
Flavian-Ștefan RădulescuCenter for Drug Sciences, Faculty of Pharmacy, University of Medicine and Pharmacy Carol Davila Bucharest, #6 Traian Vuia Street, 025956 Bucharest, Romania.
Victor VoicuSection of Medical Science, Romanian Academy, Calea Victoriei # 125, 010071 Bucharest, Romania.
Andrei-Valentin MedvedoviciDepartment of Analytical & Physical Chemistry, Faculty of Chemistry, University of Bucharest, Panduri Ave. # 90-92, 050663 Bucharest, Romania.ORCID 0000-0003-2647-2906

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clozapine and its metabolites require close therapeutic monitoring (TDM) in patients due to poor correlation between the administrated doses and resulting plasma concentrations, the narrow therapeutic interval, high inter-individual variability, and the risk of serious side effects once toxic levels are exceeded. The aim of the study was to develop a simple (relatively cheap) LC-UV method for the quantification of clozapine and its metabolites in plasma and urine samples. For sample preparation, liquid-liquid extraction (LLE) in

Indexed as

ClozapineDrug MonitoringLiquid-Liquid ExtractionAntipsychotic AgentsChromatography, High Pressure LiquidHumansAntipsychotic AgentsClozapineclozapineHPLC-DADLLEmetabolitesn-octanolSUPRAS

Identifiers

PMID39519680
PMCPMC11547683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.